HIGHLIGHTS
- What: The authors aimed to investigate the predictive value of platelet/albumin ratio (PAR) in coronary slow flow patients (CSF). In this study, the effects and potential predictive value of PAR on CSF were investigated, which had not been examined before in this patient group. The results of the study show that PAR shows a significant difference among CSF patients, which may be a useful biomarker for the understanding and management of 306 CSF. In the study , PNI was calculated and evaluated to see other outcomes that may be affected by albumin.
- Who: M E . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.